KMT2A and acute myeloid leukemia: All yet tested direct MLL fusions (MLL-X) activate a distinct set of HOXA genes, generating a distinct HOXA profile, which differs slightly in AML or ALL patients but always activate HOXA9. HOXA proteins are per se able to form complexes with MEIS and PBX proteins [17].